Related Experiment Video
Updated: May 26, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Vulnerable plaque and inflammation: potential clinical strategies
Maria Drakopoulou1, Konstantinos Toutouzas, Archontoula Michelongona
1First Department of Cardiology, Hippokration Hospital, Athens, Greece.
Current Pharmaceutical Design
|December 30, 2011
Summary
Inflammation drives the development and progression of vulnerable atherosclerotic plaques, a major cause of cardiovascular disease. New diagnostic and therapeutic strategies targeting inflammation offer hope for reducing cardiovascular events.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathophysiology
Background:
- Cardiovascular disease remains a leading global cause of mortality despite significant advancements.
- Atherosclerosis involves inflammation at all stages, crucial for vulnerable plaque development and instability.
- Understanding vulnerable plaque pathophysiology is key to developing new interventions.
Purpose of the Study:
- To review the inflammatory processes in atherosclerotic cardiovascular disease.
- To discuss diagnostic modalities for detecting local plaque inflammation.
- To explore therapeutic strategies for stabilizing vulnerable plaques by inhibiting inflammation.
Main Methods:
- Literature review focusing on inflammation in atherosclerosis.
- Analysis of current and emerging diagnostic imaging techniques for vulnerable plaques.
- Evaluation of therapeutic approaches targeting plaque inflammation.
Main Results:
- Local and systemic inflammation significantly impact plaque progression and destabilization.
- Novel imaging techniques enable early detection of vulnerable plaques.
- Therapeutic strategies including stenting, photodynamic therapy, and pharmaceuticals aim to inhibit inflammation and stabilize plaques.
Conclusions:
- Targeting inflammation is a promising strategy to combat atherosclerotic cardiovascular disease.
- Early detection of vulnerable plaques through advanced imaging is crucial.
- Inhibiting inflammatory pathways holds potential for reducing cardiovascular events.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:38Inflammation
Overview
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...